Recent studies have identified various molecules for both therapeutic targets and prognostic predictors in gliomas, including RGS16, NLR, TMEM7, SLAMF8, LINC00152, and NUSAP1.27, 28, 29, 30, 31, 32, 33. This evidence concerns the gene NUSAP1 and glioma.